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Introduction {#sec006}
============

The success of highly active antiretroviral therapy (HAART) over the past decades has increased the life expectancy among people living with HIV (PLWH) \[[@pone.0233501.ref001]\]. PLWH have increased co-morbidities, including bone fractures, which have emerged to become an important healthcare issue \[[@pone.0233501.ref002]\]. PLWH experience a greater risk of fractures, ranging from 1.6 to 3 times that of the general population \[[@pone.0233501.ref003]\]. The risk of fracture among PLWH has been associated with an increasing rate of osteoporosis due to accelerated bone loss \[[@pone.0233501.ref004], [@pone.0233501.ref005]\], bone microstructure alterations, and a reduction in bone mineral density \[[@pone.0233501.ref006]\]. The International Osteoporosis Foundation noted that bone fractures result in chronic pain, long-term disability, and even death \[[@pone.0233501.ref007]\].

A proactive approach in the prevention and treatment program is needed to minimize the consequence of bone loss and morbidity associated with fractures among PLWH \[[@pone.0233501.ref008]\]. Therefore, identifying the prevalence, incidence, and risk factors for fractures among PLWH is important to evaluate a prevention program. However, the current prevalence and incidence rate data are varied. Previous studies have focused on the high prevalence of osteoporosis among PLWH (15%) but not fracture risk \[[@pone.0233501.ref009]\]. A cohort study of PLWH identified a fracture incidence rate of 31 per 1000 person-year \[[@pone.0233501.ref010]\], however, a rate of 13.5 per 1000 person-year was reported in another study \[[@pone.0233501.ref003]\]. Arnsten's study \[[@pone.0233501.ref010]\] only included older subjects (≥ 49 years), while older age was found as a risk factor for fractures among PLWH in a study by Dong et al \[[@pone.0233501.ref011]\].

The risk factors for fracture among PLWH remain unclear. Previous studies have been limited to select HIV populations or have included osteoporosis, not fractures, as an outcome. Earlier studies on fracture risk factors among PLWH showed a varied result. A study by Bedimo et al. found the exposure to tenofovir (TDF) regimen was the risk factors for fracture \[[@pone.0233501.ref012]\]. Meanwhile, Arnsten et al. found low bone mineral density (BMD) as a significant risk factor for fracture \[[@pone.0233501.ref010]\]

The variability of conclusive information on fracture among PLWH requires additional study. The study aimed to conduct a systematic review, and meta-regression to determine the pooled prevalence, incidence rate of fracture and fracture risk factors among PLWH.

Methods {#sec007}
=======

Search strategy {#sec008}
---------------

Using PRISMA guidelines for a systematic review, databases were searched up to 9 August 2019 included PubMed, Cochrane Library, CINAHL with full text, and MEDLINE \[[@pone.0233501.ref013]\]. The terms used in the searches varied according to the database utilized, thus included *HIV*, *Human Immunodeficiency Virus*, *Acquired Immunodeficiency Syndrome*, *bone fracture*, *bone fragility*, *broken bone*, *osteoporosis*, *bone density*, *prevalence*, *incidence*, *risk factor*, *and epidemiology*.

A study was eligible for inclusion if it included HIV-infected subjects aged 16 years old or above and reported fracture prevalence or incidence rate data. Cross-sectional, cohort, and case-control studies with or without a control group were included. Studies were excluded if they were not in English. Two researchers (IP, LL) independently screened all titles, abstracts, and full texts and appraised study quality. The disagreement was resolved by a third researcher (CY).

Data extraction {#sec009}
---------------

Data extraction included author, year of publication, study location, study design, demographics, sample size, prevalence and incidence rates of fracture, and method of fracture classification. Prevalence of fracture was expressed as a percentage of fracture among HIV positive patients from the total of HIV positive patients. Incidence was expressed as the number of fractures divided by the period of risk for all included subjects. Prevalence and incidence rate data were obtained from the studies selected. All reported cases of osteoporosis in the included studies were diagnosed by using Dual-Energy X-ray Absorptiometry (DXA). When data was not provided, the prevalence rate was calculated by determining the number of fractures of the total HIV positive sample.

Quality assessment {#sec010}
------------------

Study quality was assessed using the Joanna Briggs Institute (JBI) critical appraisal checklist tool for a prevalence study \[[@pone.0233501.ref014]\] The checklist consists of nine questions with four categories of answers: yes, no, unclear, and not applicable (insufficient data). "Yes" is scored as 1 and "no" is scored as 0, with a total quality score ranging from 0--9.

Data analysis {#sec011}
-------------

Pooled estimates used a random-effects model because of heterogeneity indicated by the I^2^ statistic (values of \<25%, 25--75%, and \>75% representing low, medium, and high heterogeneity, respectively) \[[@pone.0233501.ref015]\]. Subgroup analysis and meta-regression were performed to determine potential sources of heterogeneity. Publication bias test were performed using Egger test and Funnel plot. Statistical analysis was conducted using the Comprehensive Meta-Analysis Software (Version 3.0 Biostat, Englewood, New Jersey, USA).

Results {#sec012}
=======

Four databases provided 843 articles from the year 2000 to February 2017 ([Fig 1](#pone.0233501.g001){ref-type="fig"}). After excluding duplicates, and applying inclusion and exclusion criteria, 45 articles remained. After full-text examination, 21 articles remained for quality appraisal with all receiving a quality score above 7. Twelve studies received a score of 8 out of 9, and the remaining received a score of 9 out of 9 (Supporting information). Overall, the study quality was acceptable.

![Flow diagram describing article selection according to PRISMA guidelines.](pone.0233501.g001){#pone.0233501.g001}

Study characteristics {#sec013}
---------------------

Published between 2008 and 2017, all 21 studies, were conducted in developed countries. Eleven were in Europe, nine were in the United States, and the other one was a multi-countries study conducting in the European country, Israel, and Argentina ([Table 1](#pone.0233501.t001){ref-type="table"}). Thirteen studies reported the prevalence and incidence data \[[@pone.0233501.ref016]--[@pone.0233501.ref028]\] while 8 studies reported prevalence data only \[[@pone.0233501.ref006], [@pone.0233501.ref029]--[@pone.0233501.ref035]\].

10.1371/journal.pone.0233501.t001

###### Characteristic of studies reporting prevalence or incidence of bone fracture among PLWH (n = 21).

![](pone.0233501.t001){#pone.0233501.t001g}

  Author (year)                                       Country           Study design           Population      Sample size (N)   Male (%)   Race (%)         Age (years)                      HAART exposure (%)   Fracture ascertainment           Fracture prevalence (%)   Fracture incidence (per 1000 py)
  --------------------------------------------------- ----------------- ---------------------- --------------- ----------------- ---------- ---------------- -------------------------------- -------------------- -------------------------------- ------------------------- ----------------------------------
  Ciulini et al (2017) \[[@pone.0233501.ref006]\]     Italy             Cross-sectional        All HIV (+)     141               87.2       86.5 Caucasian   43.0, 37.0--52.0                 93.6                 Semiquantitative/ morphometric   13.5                      \-
  13.5 Other                                          (median, IQR)                                                                                                                                                                                                           
  Borges et al (2017) \[[@pone.0233501.ref016]\]      Multi-countries   Prospective cohort     All HIV (+)     11820             75.0       86 White         49.0                             96.4                 Self-report                      4.2                       7.2
  3 Asia                                                                                                                                                                                                                                                                      
  5 Black                                                                                                                                                                                                                                                                     
  6 Other                                                                                                                                                                                                                                                                     
  Battalora et al (2016) \[[@pone.0233501.ref017]\]   USA               Prospective cohort     All HIV(+)      1006              83.2       67 White         43.0, 36.0--49.0                 96.0                 Self-report                      8.4                       20.9
  21.1 Black                                          (median, IQR)                                                                                                                                                                                                           
  8.9 Hispanic                                                                                                                                                                                                                                                                
  3 Other                                                                                                                                                                                                                                                                     
  Sharma et al (2015) \[[@pone.0233501.ref018]\]      USA               Prospective cohort     HIV(+) women    1713              0          24 White         40.0, 34.0--46.0                 63.0                 Self-report                      17.5                      21.9
  59 Black                                            (median, IQR)                                                                                                                                                                                                           
  17 Hispanic                                                                                                                                                                                                                                                                 
  Gazzola et al (2015) \[[@pone.0233501.ref029]\]     Italy             Cross-sectional        All HIV (+)     194               73.0       91.0 Caucasian   49.0, 40.0--51.0                 71.0                 Semiquantitative/ morphometric   12.4                      
  (median, IQR)                                                                                                                                                                                                                                                               
  Byrne et al (2015) \[[@pone.0233501.ref019]\]       USA               Retrospective cohort   All HIV (+)     96253             61.7       27 White         40.9                             100                  ICD codes                        0.8                       2.1
  56.1 Black                                                                                                                                                                                                                                                                  
  21.8 Hispanic                                                                                                                                                                                                                                                               
  5.1 Other                                                                                                                                                                                                                                                                   
  Short et al (2014) \[[@pone.0233501.ref030]\]       UK                Cross-sectional        HIV (+) men     168               100        97 Caucasian     45.0, 38.0--51.0                 78.0                 Self-report                      13.7                      \-
  (median, IQR)                                                                                                                                                                                                                                                               
  Porcelli et al (2014) \[[@pone.0233501.ref031]\]    Italy             Cross-sectional        All HIV (+)     131               71.0       \-               51.0, 36.0--75.0                 \-                   Semiquantitative/ morphometric   26.7                      \-
  (median, IQR)                                                                                                                                                                                                                                                               
  Borderi et al (2014) \[[@pone.0233501.ref032]\]     Italy             Cross-sectional        All HIV (+)     202               68.0       13.8 Caucasian   51.0                             86                   Semiquantitative/ morphometric   23.3                      \-
  Peters et al (2013) \[[@pone.0233501.ref033]\]      UK                Cross-sectional        All HIV (+)     222               60.0       48.0 Caucasian   45.6, 9.3                        85                   Self-report                      20.3                      \-
  4 Asian                                             (mean, SD)                                                                                                                                                                                                              
  38.0 Africa                                                                                                                                                                                                                                                                 
  10 Other                                                                                                                                                                                                                                                                    
  Maalouf et al (2013) \[[@pone.0233501.ref020]\]     USA               Retrospective cohort   All HIV (+)     56660             98.2       34.8 White       43.5, 36.7--51.8                 64.2                 ICD codes                        1.4                       2.07
  (median, IQR)                                                                                                                                                                                                                                                               
  Guerri et al (2013) \[[@pone.0233501.ref021]\]      Spain             Retrospective cohort   All HIV (+)     2489              75.3       \-                                                \-                   ICD codes                        2.0                       8.03
  Yin et al (2012) \[[@pone.0233501.ref022]\]         USA               Prospective cohort     All HIV (+)     4640              83.4       48.0 White       39.0, 33.0--45.0                 99.7                 Self-report                      2.3                       4.0
  28.7 Black                                          (median, IQR)                                                                                                                                                                                                           
  20.4 Hispanic                                                                                                                                                                                                                                                               
  1.8 Asian                                                                                                                                                                                                                                                                   
  1.2 Other                                                                                                                                                                                                                                                                   
  Torti et al (2012) \[[@pone.0233501.ref034]\]       Italy             Cross-sectional        HIV (+) men     160               100        \-               53.0, 42.0--71.0                 78.1                 Semiquantitative/ morphometric   26.9                      \-
  (median, IQR)                                                                                                                                                                                                                                                               
  Lo re et al (2012) \[[@pone.0233501.ref023]\]       USA               Retrospective cohort   All HIV (+)     95827             63.1       27.3 White       39.0, 33.0--46.0 (median, IQR)   \-                   ICD codes                        0.8                       1.95
  44.4 Black                                                                                                                                                                                                                                                                  
  8.5 Hispanic                                                                                                                                                                                                                                                                
  19.9 Other                                                                                                                                                                                                                                                                  
  Hansen et al (2012) \[[@pone.0233501.ref024]\]      Denmark           Prospective cohort     All HIV (+)     5306              76.0       80 White         36.7, 30.5--44.5                 78.0                 ICD codes                        15.2                      21.0
  20 Other                                            (median, IQR)                                                                                                                                                                                                           
  Young et al (2011) \[[@pone.0233501.ref025]\]       USA               Prospective cohort     All HIV (+)     5826              79.0       \-               40.0, 34.0--46.0                 73.0                 ICD codes                        4.0                       8.9
  (median, IQR)                                                                                                                                                                                                                                                               
  Hasse et al (2011) \[[@pone.0233501.ref026]\]       Swiss             Prospetive cohort      All HIV (+)     8444              70.8       \-               \-                               85.0                 Self-report                      1.5                       5.5
  Guaraldi et al (2011) \[[@pone.0233501.ref035]\]    Italy             Case control           All HIV (+)     2854              63.0       \-               46.0                             \-                   ICD codes                        14.2                      \-
  Yin et al (2010) \[[@pone.0233501.ref027]\]         USA               Prospective cohort     HIV (+) women   1728              0          13.3 White       40.4, 8.8                        65.6                 Self-report                      8.6                       17.9
  56.3 Black                                          (mean, SD)                                                                                                                                                                                                              
  27.2 Latina                                                                                                                                                                                                                                                                 
  3.2 Others                                                                                                                                                                                                                                                                  
  Triant et al (2008) \[[@pone.0233501.ref028]\]      USA               Prospective cohort     All HIV (+)     8525              65.2       17.9 Black       \-                               \-                   Self-report                      2.9                       24.9
  55.1 White                                                                                                                                                                                                                                                                  
  15.4 Hispanic                                                                                                                                                                                                                                                               
  11.6 Other                                                                                                                                                                                                                                                                  

PLWH = people living with HIV; HAART = highly active antiretroviral therapy; ICD = international classification of disease; py = person-years; IQR = interquartile-range; SD = standard deviation

Of the twenty-one studies reporting fracture prevalence, the sample size ranged from 131 in Porcelli et al.'s cross-sectional study in Italy \[[@pone.0233501.ref031]\] to 96,253 in the retrospective' study by Byrne et al. in the United States \[[@pone.0233501.ref019]\] ([Table 1](#pone.0233501.t001){ref-type="table"}). Ethnicity included Caucasian, Black, Hispanic, and Asian subjects. In each study the majority of subjects were men. Subject age, provided by eighteen studies, ranged from 36.7 \[[@pone.0233501.ref024]\] to 49 \[[@pone.0233501.ref016], [@pone.0233501.ref029]\] years. Sixteen studies provided the percentage of participants that receive highly active antiretroviral therapy (HAART) which ranged from 63% \[[@pone.0233501.ref018]\] to 100% \[[@pone.0233501.ref019]\]. Nine studies used self-report \[[@pone.0233501.ref016]--[@pone.0233501.ref018], [@pone.0233501.ref022], [@pone.0233501.ref026]--[@pone.0233501.ref028], [@pone.0233501.ref030], [@pone.0233501.ref033]\], seven studies applied ICD codes \[[@pone.0233501.ref019]--[@pone.0233501.ref021], [@pone.0233501.ref023]--[@pone.0233501.ref025], [@pone.0233501.ref035]\] and five studies used X-ray lateral semiquantitative method \[[@pone.0233501.ref006], [@pone.0233501.ref029], [@pone.0233501.ref031], [@pone.0233501.ref032], [@pone.0233501.ref034]\].

Of the thirteen studies reporting fracture incidence, nine were conducted in the United States \[[@pone.0233501.ref017]--[@pone.0233501.ref020], [@pone.0233501.ref022], [@pone.0233501.ref023], [@pone.0233501.ref025], [@pone.0233501.ref027], [@pone.0233501.ref028]\], and one each in Spain \[[@pone.0233501.ref021]\], Denmark \[[@pone.0233501.ref024]\], and Switzerland \[[@pone.0233501.ref026]\], with a multinational study reported from Europe \[[@pone.0233501.ref016]\] ([Table 1](#pone.0233501.t001){ref-type="table"}). The sample size varied from 1,006 in Battalora et al.'s prospective cohort study \[[@pone.0233501.ref017]\] to 96,253 in a retrospective study by Byrne et al. \[[@pone.0233501.ref019]\]. In each study, the majority of the subjects were men. Age range and HAART exposure for fracture incidence were similar to studies reporting fracture prevalence. Seven studies used self-report \[[@pone.0233501.ref016]--[@pone.0233501.ref018], [@pone.0233501.ref022], [@pone.0233501.ref026]--[@pone.0233501.ref028]\] while six studies used ICD codes to ascertain fracture incidence \[[@pone.0233501.ref019]--[@pone.0233501.ref021], [@pone.0233501.ref023]--[@pone.0233501.ref025]\].

Bone fracture prevalence {#sec014}
------------------------

The pooled prevalence of the 21 studies reporting bone fracture among people living with HIV (PLWH) was 6.6% (3.8--11.1) with a high level of heterogeneity ([Table 2](#pone.0233501.t002){ref-type="table"}). The prevalence of PLWH was higher than in the general population with an odds ratio of 1.9 (95% CI: 1.1--3.2) ([Fig 2](#pone.0233501.g002){ref-type="fig"}). Males showed a higher prevalence compared to females (6.2% vs 4.9%, respectively). The injecting drugs users (IDUs) PLWH showed the highest prevalence of fracture (8.6%) among the risk group. PLWH who are receiving HAART showed a higher prevalence of fracture compared to those without HAART (6.7% vs 3.5%, respectively).

![Forest plot for fracture odds ratio between PLWH and general population.](pone.0233501.g002){#pone.0233501.g002}

10.1371/journal.pone.0233501.t002

###### Prevalence of fracture among people living with HIV by demographic variable in selected studies.

![](pone.0233501.t002){#pone.0233501.t002g}

                                 Number of studies   Prevalence (%) (95% CI)   Sample size   I^2^ (%)
  ------------------------------ ------------------- ------------------------- ------------- ----------
  Overall fracture prevalence    21                  6.6 (3.8--11.1)           304309        99.8
  **Subgroup analysis**                                                                      
  Gender                                                                                     
      Female                     9                   4.9 (3.2--7.4)            9393          91.9
      Male                       9                   6.2 (3.6--10.4)           79632         99.1
  Age                                                                                        
      \<41 y.o                   3                   4.4 (1.8--10.4)           4925          97.3
      41--50 y.o                 3                   5.8 (1.9--16.5)           7455          99.2
      51--60 y.o                 2                   7.5 (1.8--26.5)           2614          98.6
      \>60 y.o                   2                   7.9 (3.2--18.3)           806           89.8
  BMI                                                                                        
      \< 18                      2                   6.4 (5.1--8.2)            990           0.0
      18--29.9                   3                   6.6 (2.5--16.4)           11089         98.3
      \>29.9                     3                   4.7 (0.8--24.5)           9579          98.7
  HIV risk factor                                                                            
      Heterosexual               2                   6.2 (2.6--13.8)           3822          92.4
      IDUs                       6                   8.6 (4.1--17.0)           22399         97.7
      MSM                        2                   5.5 (2.4--12.0)           5669          96.7
      Other risk                 2                   4.2 (3.0--5.7)            906           0.0
  HAART exposure                                                                             
      With HAART                 5                   6.7 (3.8--11.3)           20727         98.2
      Without HAART              5                   3.5 (1.9--6.2)            5210          84.9
  Race/ethnicity                                                                             
      White                      5                   3.9 (2.6--5.8)            34858         97.4
      Black                      5                   3.3 (2.1--5.0)            5754          86.5
      Caucasian                  3                   3.8 (3.2--4.4)            4531          0.0
      Hispanic                   4                   3.3 (1.6--6.6)            3050          89.7
      Others                     4                   3.0 (2.1--4.3)            3158          0.0
      Country region                                                                         
          European               11                  12.0 (7.0--19.7)          20311         98.9
          America                9                   3.2 (1.6--6.4)            272178        99.8
          Multi-countries        1                   4.2 (3.8--4.6)            11820         0.0
      Fracture ascertainment                                                                 
          ICD codes              7                   3.0 (1.0--8.1)            265215        99.9
          Semi-quantitative      5                   20.0 (14.6--26.9)         828           79.6
          Self-report            9                   6.4 (3.6--11.1)           38266         99.2
      Study design                                                                           
          Case control           1                   14.2 (13.0--15.5)         2854          0.0
          Cross sectional        7                   19.2 (15.0--24.1)         1218          75.3
          Retrospective cohort   4                   1.1 (0.8--0.9)            251229        98.0
          Prospective cohort     9                   5.4 (3.0--9.5)            49008         99.5

BMI = body mass index; IDUs = inject drugs users; MSM = male sex with male; HAART = highly active anti-retroviral therapy; CI = confidence interval ICD = international classification of disease

Bone fracture incidence {#sec015}
-----------------------

The pooled incidence of the 13 reports bone fracture among people living with HIV (PLWH) was 11.3 per 1000-person years (95% CI: 7.9--14.3) with a high level of heterogeneity ([Table 3](#pone.0233501.t003){ref-type="table"}). The pooled rate ratio was calculated from six studies reporting fractures of the control group as 1.5 (95% CI: 1.3--1.8) ([Fig 3](#pone.0233501.g003){ref-type="fig"}).

![Forest plot for fracture incidence rate ratio between PLWH and general population.](pone.0233501.g003){#pone.0233501.g003}

10.1371/journal.pone.0233501.t003

###### Incidence of fracture among people living with HIV by demographic variable in selected studies.
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                                       Number of studies   Incidence (per 1000 py) (95% CI)   Sample size   I^2^ (%)
  ------------------------------------ ------------------- ---------------------------------- ------------- ----------
  Overall fracture incidence           13                  11.3 (7.9--14.5)                   300237        99.9
  *Subgroup analysis*                                                                                       
  Country region                                                                                            
      European                         3                   11.5 (4.1--18.9)                   16239         99.9
          America                      9                   12.0 (7.8--16.3)                   272178        99.9
          Multi-countries              1                   7.2 (7.0--7.4)                     11820         0.0
  Fracture ascertainment                                                                                    
      ICD codes                        6                   7.3 (4.0--10.7)                    262361        99.9
      Self-report                      7                   15.2 (6.2--12.1)                   37876         99.9
      Study design                                                                                          
          Retrospective cohort         4                   3.5 (1.7--5.4)                     251229        99.9
      Prospective cohort               9                   15.1 (10.0--20.2)                  49008         99.9
          Overall fracture incidence   13                  11.3 (7.9--14.5)                   300237        99.9
          *Subgroup analysis*                                                                               
          Country region                                                                                    
  European                             3                   11.5 (4.1--18.9)                   16239         99.9
  America                              9                   12.0 (7.8--16.3)                   272178        99.9
  Multi-countries                      1                   7.2 (7.0--7.4)                     11820         0.0
      Fracture ascertainment                                                                                
      ICD codes                        6                   7.3 (4.0--10.7)                    262361        99.9
      Self-report                      7                   15.2 (6.2--12.1)                   37876         99.9
  Study design                                                                                              
      Retrospective cohort             4                   3.5 (1.7--5.4)                     251229        99.9
      Prospective cohort               9                   15.1 (10.0--20.2)                  49008         99.9

ICD = international classification of disease; py = person-years; CI = confidence interval

Fracture risk factors {#sec016}
---------------------

Traditional risk factors for fracture identified among PLWH included older age (\> 60 years), smoking, and osteoporosis with adjusted hazard ratios (aHR) of 1.4, 1.3, 3.3, respectively ([Table 4](#pone.0233501.t004){ref-type="table"}). HCV co-infection was an independent HIV-related risk factor with an adjusted hazard ratio of 1.6 (95% CI: 1.3--1.9).

10.1371/journal.pone.0233501.t004

###### Risk factor of fractures among people living with HIV.
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  Risk factor              Sample size   Adjusted Hazard Ratio (CI 95%)   I^2^    P value
  ------------------------ ------------- -------------------------------- ------- ----------------------------------------------
  Older age (\>60 years)   32302         1.4 (1.3--1.6)                   57.73   0.001[\*\*](#t004fn003){ref-type="table-fn"}
  Female gender            12038         1.2 (0.9--1.5)                   0.00    0.258
  Nadir CD4 cells count    23858         1.0 (0.9--1.1)                   7.89    0.844
  Smoking                  18032         1.3 (1.1--1.5)                   66.41   0.010[\*](#t004fn002){ref-type="table-fn"}
  HCV coinfection          18652         1.6 (1.3--1.9)                   0.00    0.001[\*\*](#t004fn003){ref-type="table-fn"}
  Lower BMI                12826         1.2 (0.9--1.8)                   85.19   0.281
  Prior fracture           12826         2.2 (0.7--7.1)                   87.58   0.168
  Osteoporosis             12826         3.3 (2.2--5.1)                   0.00    0.001[\*\*](#t004fn003){ref-type="table-fn"}

CI = confidence interval; HCV = Hepatitis C Co-infection; BMI = body mass index

\* refers to p \<0.05

\*\* refers to p \< 0.005

Meta-regression analysis and publication bias {#sec017}
---------------------------------------------

A high level of heterogeneity existed across the studies reporting prevalence (I^2^ = 99.8%, [Table 2](#pone.0233501.t002){ref-type="table"}). Univariate analysis was conducted to find significant independent covariates as a potential source of heterogeneity that could be included in a meta-regression model ([Table 5](#pone.0233501.t005){ref-type="table"}). The covariates of study design (p \< 0.001) and fracture identification method (p \< 0.05) showed significant coefficient regression. After these covariates were included in the meta-regression analysis, only study design covariates provided a significant coefficient regression (p \< 0.05). Publication bias was analyzed by generating a funnel plot and Egger's test with neither demonstrating evidence of asymmetry ([Fig 4](#pone.0233501.g004){ref-type="fig"}).

![Funnel plot for publication bias test across studies.](pone.0233501.g004){#pone.0233501.g004}

10.1371/journal.pone.0233501.t005

###### Meta-regression analysis of fracture risk factors affecting heterogeneity on prevalence [^a^](#t005fn002){ref-type="table-fn"}.

![](pone.0233501.t005){#pone.0233501.t005g}

  Variable                              Univariate coefficient (95% CI)   P value                                           Multivariate Coefficient (95% CI) [^b^](#t005fn003){ref-type="table-fn"}   P value
  ------------------------------------- --------------------------------- ------------------------------------------------- -------------------------------------------------------------------------- --------------------------------------------
  Country region                                                                                                                                                                                       
      Reference: America                                                                                                                                                                               
      Europe                            1.4 (0.5--2.3)                    0.003[\*](#t005fn001){ref-type="table-fn"}        0.1 (-0.9--0.9)                                                            0.994
      Multi-country                     0.3 (-1.9--2.5)                   0.807                                             -0.2 (-1.7--1.4)                                                           0.836
  Study design                                                                                                                                                                                         
      Reference: Retrospective cohort                                                                                                                                                                  
      Case control                      2.6 (1.1--4.2)                    P \< 0.001[\*](#t005fn001){ref-type="table-fn"}   2.6 (0.9--4.4)                                                             0.003[\*](#t005fn001){ref-type="table-fn"}
      Cross-sectional                   3.0 (2.1--3.9)                    P \< 0.001[\*](#t005fn001){ref-type="table-fn"}   3.4 (1.3--5.4)                                                             0.001[\*](#t005fn001){ref-type="table-fn"}
      Prospective cohort                1.6 (0.7--2.4)                    P \< 0.001[\*](#t005fn001){ref-type="table-fn"}   2.0 (0.7--3.3)                                                             0.002[\*](#t005fn001){ref-type="table-fn"}
  Fracture ascertainment                                                                                                                                                                               
      Reference: ICD codes                                                                                                                                                                             
      Self-report                       0.8 (-0.5--2.1)                   0.217                                             -0.5 (-1.7--0.7)                                                           0.402
      Semi-quantitative                 2.1 (0.6--3.6)                    0.006[\*](#t005fn001){ref-type="table-fn"}        -0.3 (-2.0--1.4)                                                           0.722

\* refers to statistically significant at p \< 0.05

^a^ refers to I^2^ statistic result (99%)

^b^ refers to Confidence Interval

Discussion {#sec018}
==========

The findings of this study revealed that people living with HIV have an increased risk of bone fracture, 1.9 times higher than that observed in the general population. This finding was higher than a systematic review of HIV postmenopausal women that reported a fracture prevalence 1.5 times greater than HIV negative postmenopausal women \[[@pone.0233501.ref036]\]. The greater percentage of males in the studies included in the current study may explain the difference.

People living with HIV experienced an incidence rate of fracture 1.5 times that of the general population. Dong and colleagues' meta-analysis reported a similar incidence rate ratio of fracture among PLWH of 1.8 \[[@pone.0233501.ref011]\]. However, the analysis only focused on subjects with HIV and HCV co-infection which may have yielded a higher incidence rate ratio. Maalouf et al. have reported a higher risk of fracture among patients with HIV/HCV co-infection compared to HIV mono-infection which was identified as a risk factor in the current study \[[@pone.0233501.ref020]\].

The four risk factors found significant in this meta-analysis have previously reported including older age, osteoporosis, smoking and HCV co-infection. A meta-analysis by Shiau et al. identified similar results but did not report pooled hazard ratios \[[@pone.0233501.ref037]\]. Older age as a traditional risk factor in this study was reported in a meta-analysis by Dong et al. who studied risks among HIV and HCV co-infected patients \[[@pone.0233501.ref011]\]. Osteoporosis as a risk factor for fractures showed a lower pooled adjusted hazard ratio than Short et al. \[[@pone.0233501.ref038]\] who reported that HIV infected men with osteoporosis had a 3.5-fold risk of fracture compared to those without osteoporosis. However, the limited population of the study may have overestimated the findings. Smoking, a significant and modifiable fracture risk factor among PLWH, is associated with a bone mineral density which is influenced by both dose and duration of smoking \[[@pone.0233501.ref039]\]. Wu et al. \[[@pone.0233501.ref040]\] reported that smokers had twice the risk of fracture compared to non-smokers. Smoking cessation programs among smokers with HIV may reduce fracture risk after just three months \[[@pone.0233501.ref041]\]. The HCV co-infection risk, with pooled aHR of 1.6, confirms the findings of Dong et al's meta-analytic study. \[[@pone.0233501.ref011]\]. Another meta-analytic study by Shiau et al. \[[@pone.0233501.ref037]\] also found that HCV co-infection was an independent risk factor for both fragility and non-fragility fractures. Early intervention for HCV co-infection and PLWH, recommended by Bedimo et al. is critical to reducing bone turnover \[[@pone.0233501.ref042]\]

The current study adds to the literature by reporting both the prevalence and incidence rate of fractures including the HIV-related risk factor for fracture among people living with HIV. The studies included in the meta-analysis included sample sizes exceeding 1,000 and a diverse population of patients with HIV. Previous reviews focused on smaller samples with at-risk populations. Finally, a pooled adjusted Hazard Ratio of fracture risk factors provide more specific analysis than a simple summary of factors.

Limitations {#sec019}
-----------

The literature search excluded non-English reports as the studies all originated in developed countries, fracture risk factors of less developed countries may differ. Despite subgroup and meta-regression analysis, the synthesized literature revealed significant heterogeneity.

Conclusions {#sec020}
===========

A comprehensive meta-analysis revealed a higher prevalence and incidence rate of fracture among PLWH compared to the general population. Smoking, older age, osteoporosis, and HCV coinfection are significant risk factors for fracture among PLWH.

Our finding highlights a higher risk of fracture among PLWH compared to the general population. Osteoporosis, smoking and HIV/HCV coinfection as the significant modifiable risk factors should be prioritized by the HIV health provider when managing PLWH. Further investigation of the interactions among risk factors is urgently needed to prevent bone fractures.
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